A point mutation (Arg271→Cys) of a homozygote for dysfunctional prothrombin, prothrombin Obihiro, which has a region of high sequence variability
Authors:
- 1 July 1995
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 90 (3) , 688-692
Abstract
Summary. The molecular defect of a congenitally dysfunctional form of prothrombin, prothrombin Obihiro, was identified in a patient with a severe bleeding tendency. He showed reduced fibrinogen clotting activity, despite a normal prothrombin antigen level. Nucleotide sequencing of amplified DNA revealed a C→T change at nucleotide 7311 of exon VIII of the prothrombin gene. This resulted in the substitution of Arg271 by Cys at the factor Xa cleavage site which precludes normal activation of prothrombin Obihiro by factor Xa and the generation of thrombin. The proband was homozygous for this mutation. In addition, seven new nucleotide changes were identified in the prothrombin gene of this patient by comparison with the published gene sequence. Three polymorphisms at nucleotides 4291, 4298 and 7223 were exclusively identified in the prothrombin gene from Japanese. Particularly in the region containing exon VI and introns E and F (nucleotides 4048‐4303), the prothrombin gene proved to be of high‐sequence variability.Keywords
This publication has 14 references indexed in Scilit:
- Prothrombin Padua I: incomplete activation due to an amino acid substitution at a factor Xa cleavage siteBlood Coagulation & Fibrinolysis, 1994
- Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activityBiochemistry, 1992
- Highly polymorphic region of the human prothrombin (F2) geneHuman Genetics, 1992
- Ncol RFLP in the human prothrombin (F2) geneNucleic Acids Research, 1991
- Molecular defects of factor IX Chicago-2 (Arg 145----His) and prothrombin Madrid (Arg 271----cys): arginine mutations that preclude zymogen activationBlood, 1989
- Substitution of valine for glycine-558 in the congenital dysthrombin thrombin Quick II alters primary substrate specificityBiochemistry, 1989
- Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382Biochemistry, 1988
- Nucleotide sequence of the gene for human prothrombinBiochemistry, 1987
- Prothrombin Tokushima, a replacement of arginine-418 by tryptophan that impairs the fibrinogen clotting activity of derived thrombin TokushimaBiochemistry, 1987
- Activation of prothrombin Barcelona evidence for active high molecular weight intermediatesBiochimica et Biophysica Acta (BBA) - General Subjects, 1979